ArticleIndian journal of anaesthesia2026
Use of intranasal insulin on postoperative delirium: A systematic review and meta-analysis of randomised controlled trials.
Article in Indian journal of anaesthesia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Postoperative delirium remains a major concern among adult patients undergoing surgery. Intranasal insulin is believed to reduce postoperative delirium in adults. However, its efficacy and safety profile remain unclear. The primary objective was to examine the effects of intranasal insulin on the incidence of postoperative delirium. Secondary outcomes include serum concentration of Tissue Necrosis Factor-alpha (TNF-α), Interleukin-6 (IL-6), C-Reactive Protein (CRP), haemostasis model assessment - insulin (HOMA-IR), and serum glucose. Methods: All randomised controlled trials (RCTs) were searched in the databases of CENTRAL, EMBASE, and MEDLINE until January 2025. Case reports, case series, letters to the editor, and conference abstracts were excluded. We used Revman Version 5.4 to calculate the fixed-effects and random-effects models to report the primary and secondary outcomes by using the odds ratio (OR) and mean difference (MD), respectively, with a 95% confidence interval (CI). This review included a Grading of Recommendations Assessment, Development and Evaluation analysis on the quality of evidence for all measured outcomes. Results: Seven studies with a total of 739 patients were included in this systematic review. In comparison to intranasal saline, intranasal insulin significantly reduced the incidence of postoperative delirium among adults undergoing surgery (OR: 0.37, 95% CI: 0.22, 0.63). Its administration was also associated with a statistical decrease in the serum concentration of TNF-α (MD: -3.10, 95% CI: -4.42, -1.78), serum concentration of IL-6 (MD: -3.86, 95% CI: -5.92, -1.80), and serum concentration of CRP (MD: -1.71, 95% CI: -3.38, -0.04). However, no statistical differences were observed in the HOMA-IR and serum glucose. Conclusions: This meta-analysis highlighted the promising application of intranasal insulin in reducing the incidence of postoperative delirium, serum concentration of TNF-α, IL-6, and CRP in adult patients undergoing surgery. However, a high degree of heterogeneity and limited sample size warrant future adequately powered studies to confirm our findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.